BLA number bla_125477 granted on 4/21/2014

Trade name is Cyramza- Ramucirumab is a human monoclonal antibody (IgG1) against vascular endothelial growth factor receptor 2 (VEGFR2), a type II trans-membrane tyrosine kinase receptor expressed on endothelial cells.

www.drugbank.ca

Patent US 7498414


